Access to hepatitis C treatment for people who inject drugs in low and middle income settings: Evidence from 5 countries in Eastern Europe and Asia

The International Journal on Drug Policy
Niklas LuhmannJulie Bouscaillou

Abstract

People who inject drugs (PWID) are disproportionately affected by the hepatitis C (HCV) epidemic. Of the estimated 16 million PWID worldwide, approximately 8 million live with chronic HCV, and around 26% and 23% of the global HCV infections among PWID occur in East/Southeast Asia and Eastern Europe respectively. Globally, few PWID have access to treatment for HCV. We conducted a systematic literature review and internet survey in 2014 to document the burden of disease, access to diagnosis and treatment and the existence of national policy and treatment guidelines for HCV. We included Georgia, Russia, Ukraine, Myanmar and Indonesia as countries with injection drug use epidemics. HCV antibody prevalence among the general population ranged from 0.80% in Indonesia to 5% in Georgia, and among PWID from 48.1% in Myanmar to 92% in Georgia. PWID carried a significant burden of disease, ranging from 2.7% in Indonesia to 40.4% in Russia. Yearly treatment uptake was under 1% for the general population and PWID in all countries. Diagnostic tools and disease staging investigations as well as pegylated interferon/ribavirin treatment were available at a range of prices. Despite policy and treatment protocols for HCV in the majority of countri...Continue Reading

References

Nov 22, 2000·JAMA : the Journal of the American Medical Association·D L ThomasD Vlahov
Mar 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anna DoabGregory J Dore
Sep 15, 2007·The International Journal on Drug Policy·Carmen Aceijas, Tim Rhodes
Feb 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Daniel Lavanchy
Aug 25, 2009·Harm Reduction Journal·Kostyantyn V DumchevJoseph E Schumacher
Oct 18, 2011·Current Opinion in HIV and AIDS·Jason Grebely, Mark W Tyndall
Oct 21, 2011·AIDS Research and Human Retroviruses·Gretchen S ArnoczyUNKNOWN Center for HIV/AIDS Vaccine Immunology AI067854
Dec 23, 2011·Seminars in Liver Disease·Jason Grebely, Gregory J Dore
Jun 6, 2012·Journal of Medical Internet Research·Anne M TurnerDaniel Capurro
Aug 8, 2012·Occupational Medicine·M ButsashviliL-A McNutt
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Khayriyyah Mohd HanafiahSteven T Wiersma
Jun 19, 2013·Journal of Infection in Developing Countries·Afiono Agung PrasetyoSeiji Kageyama
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lynn E TaylorGail V Matthews
Aug 2, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maryam AlaviUNKNOWN Enhancing Treatment for Hepatitis C in Opioid Substitution Settings (ETHOS) Study Group
Jan 29, 2014·Antiviral Research·Jason Grebely, Gregory J Dore
Feb 18, 2014·The International Journal on Drug Policy·Julie BouscaillouDominique Pataut
Apr 23, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·George V PapatheodoridisHeiner Wedemeyer
Aug 3, 2014·Journal of Hepatology·Erin GowerHomie Razavi
Sep 14, 2014·Journal of the National Cancer Institute·Amanda LeiterMatthew D Galsky

❮ Previous
Next ❯

Citations

Aug 10, 2015·The International Journal on Drug Policy·Jason GrebelyUNKNOWN International Network for Hepatitis in Substance Users
Aug 10, 2015·The International Journal on Drug Policy·Jason GrebelyUNKNOWN International Network for Hepatitis in Substance Users
Aug 2, 2015·The International Journal on Drug Policy·D WolfeT Swan
Dec 7, 2016·International Journal of Prisoner Health·Joseph BickFrederick Altice
Mar 23, 2017·BMJ Open Gastroenterology·Noemi Hernández-AlvarezManuel Hernández-Guerra
Dec 7, 2016·World Journal of Gastroenterology : WJG·Naomi Khaing Than HlaingK Rajender Reddy
May 7, 2019·Frontiers in Microbiology·Mei YeYong-Tang Zheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.